Drugs & Targets FDA approves Sarclisa in patients with previously treated MM March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants RMAT designation for CD30 CAR-T cell therapy in Hodgkin lymphoma indication March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants tipifarnib Fast Track designation in T-cell lymphomas March 06, 2020Vol.46 No.10
Drugs & Targets FDA approves neratinib for metastatic HER2-positive breast cancer February 28, 2020Vol.46 No.09
Drugs & Targets FDA accepts sNDA for Zejula in ovarian cancer indication February 28, 2020Vol.46 No.09
Drugs & Targets FDA grants RMAT designation to CD30 CAR-T Cell Therapy in hodgkin lymphoma indication February 28, 2020Vol.46 No.09
Drugs & Targets PMC report: FDA addressed rare diseases, expanded cancer treatment and targeted therapies in 2019 February 28, 2020Vol.46 No.09
Drugs & Targets Boehringer Ingelheim and Trutino Biosciences collaborate to grow cancer immunology portfolio with novel cytokine platform February 28, 2020Vol.46 No.09
Drugs & Targets FDA grants capmatinib priority review in NSCLC indication February 21, 2020Vol.46 No.08
